Columbia Microbiome Sciences unveils photoprotection platform

Columbia Microbiome Sciences says it has built a patent-pending photoprotection system designed to support the skin’s natural defense and repair mechanisms, rather than only filter UV rays. CEO Steven Rosenfeld will present the latest data Oct. 8 at a New York Chapter of the Society of Cosmetic Chemists symposium in New Jersey.

Why it matters: - Skin cancer remains the most common cancer in the U.S. and globally, and the Skin Cancer Foundation says 1 in 5 Americans will develop it by age 70. - The UV protection market is growing more than 5% a year and is projected to reach $19.6 billion by 2032. - Columbia Microbiome Sciences is positioning its platform as a different kind of photoprotection, aimed at skin biology, recovery and long-term resilience.

What happened: - Columbia Microbiome Sciences announced a patent-pending photoprotection system that it says goes beyond traditional sunscreen. - CEO Steven Rosenfeld will present new data on Oct. 8, 2026, at “The Skin Barrier as a Living Interface: Biology, Disruption, and Repair.” - The symposium is produced by The New York Chapter of the Society of Cosmetic Chemists. - Roger McMullen is the symposium chair. - The event will be held at The Legacy Castle in Pequannock Township, New Jersey, from 9 a.m. to 6 p.m.

The details: - The company says the system is designed to work with the skin’s biology and help mitigate photodamage at the cellular level while preserving natural renewal processes. - Rosenfeld said sunscreen chemistry has not fundamentally changed in more than 50 years. - Rosenfeld described the platform as moving photoprotection from passive UV filtration to active biological support across the skin’s molecular, cellular and microbial layers. - The system incorporates components intended to stabilize DNA, RNA and antioxidant pathways under stress. - The platform is also designed to modulate immune response and preserve signaling used in skin recovery. - Columbia Microbiome Sciences says the system is intended to reduce downstream effects tied to cumulative photodamage. - The company says the technology is meant to enhance skin resilience under environmental exposure. - Preliminary internal evaluations indicate the approach may offer advantages over traditional sunscreen formulations for long-term skin health and visible aging linked to chronic sun exposure. - The patent-pending technology is expected to anchor a new category of photoprotection products under development. - Columbia Microbiome Sciences plans to share more data and product updates in the coming months. - The company’s website is more information. - The company’s LinkedIn page is company updates.

Between the lines: - The pitch tracks a broader shift in skincare toward products framed around skin health, not just UV blocking. - The references to microbiome balance, cellular signaling and skin longevity suggest Columbia Microbiome Sciences wants to define a new category, not just improve an existing formula. - The internal data language signals early-stage development, so the main near-term test is whether the October presentation convinces cosmetic chemists and industry attendees.

What's next: - Rosenfeld will present the latest findings at the NYSCC symposium on Oct. 8. - Columbia Microbiome Sciences says additional data and product developments are coming in the months ahead. - The company’s next step is likely to show whether the platform can move from concept and internal evaluation into commercial photoprotection products.

The bottom line: - Columbia Microbiome Sciences is trying to recast sunscreen as an active biological intervention, with skin longevity as the selling point.